Geode Capital Management
ENSC icon

Geode Capital Management’s Ensysce Biosciences ENSC Stock Holding History

Geode Capital Management’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.8K Buy
73,880
+51,790
+234% +$32.8K ﹤0.01% 4364
2025
Q4 		$20.3K Buy
22,090
+9,060
+70% +$16.8K ﹤0.01% 4385
2025
Q3 		$30.9K Buy
13,030
+2,869
+28% +$6.17K ﹤0.01% 4374
2025
Q2 		$22.7K Buy
+10,161
New +$23.3K ﹤0.01% 4348
2024
Q4 		– Sell
-3,071
Closed -$11.1K – 4484
2024
Q3 		$11.1K Sell
3,071
-2
-0.1% -$12 ﹤0.01% 4464
2024
Q2 		$23.3K Buy
3,073
+1,852
+152% +$16.9K ﹤0.01% 4427
2024
Q1 		$14.5K Buy
1,221
+136
+13% +$2.16K ﹤0.01% 4518
2023
Q4 		$17K Sell
1,085
-10
-0.9% -$161 ﹤0.01% 4539
2023
Q3 		$22.5K Buy
+1,095
New +$31.1K ﹤0.01% 4600
2022
Q4 		– Sell
-36
Closed -$28K – 4907
2022
Q3 		$28K Buy
36
+1
+3% +$1.63K ﹤0.01% 4859
2022
Q2 		$110K Buy
35
+4
+13% +$11.2K ﹤0.01% 4552
2022
Q1 		$125K Buy
31
+3
+11% +$19.8K ﹤0.01% 4572
2021
Q4 		$474K Buy
28
+13
+87% +$123K ﹤0.01% 4077
2021
Q3 		$166K Buy
+15
New +$293K ﹤0.01% 4515

Other funds holding ENSC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $163M AUM 18.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management's ENSC Position: Q1 2026 in Review

Geode Capital Management increased its Ensysce Biosciences (ENSC) stake by 234% in Q1 2026, buying an estimated $32.8K and bringing the position to 73,880 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4364.

Geode Capital Management first reported a position in ENSC in Q3 2021 and has held it in 14 quarters since. The position peaked at $474K in Q4 2021. 15 funds tracked by Wall St. Rank hold ENSC as of Q1 2026.

  • Geode Capital Management held 73,880 shares of Ensysce Biosciences worth $39.8K as of Q1 2026.
  • Geode Capital Management bought 51,790 Ensysce Biosciences shares in Q1 2026, an estimated $32.8K.
  • Ensysce Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4364 holding.
  • Geode Capital Management first reported a position in Ensysce Biosciences in Q3 2021 and has held it in 14 quarters since.
  • Geode Capital Management's Ensysce Biosciences position peaked at $474K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.